Late-Stage Pipeline Blooming At Boehringer As R&D Spend Soars
Jardiance And Ofev Sales Continue To Climb
Over the next five years, the German group is looking to invest over €25bn in the R&D pipeline, with oncology a key focus.
Over the next five years, the German group is looking to invest over €25bn in the R&D pipeline, with oncology a key focus.